KMT2A and acute lymphoblastic leukemia: It is, however, a topic of debate whether the overexpression of FLT-3 results from activating mutations, as some groups argue that FLT-3 mutations are uncommon [83] or even completely absent in MLL-r ALL [84,85,86].